High Plasma Angiopoietin-2 Levels Predict the Need to Initiate Dialysis within Two Years in Patients with Chronic Kidney Disease

• Published in: International journal of molecular sciences Vol. 24; no. 12; p. 10036
• Main Authors: Szymczak, Anna, Kusztal, Mariusz, Gołębiowski, Tomasz, Letachowicz, Krzysztof, Goździk, Anna, Kościelska-Kasprzak, Katarzyna, Tukiendorf, Andrzej, Krajewska, Magdalena
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.06.2023; MDPI
• Subjects: Analysis; Angiogenesis; Angiopoietin; Angiopoietin-1; Angiopoietin-2; Biomarkers; Brain natriuretic peptide; Cardiovascular disease; Cell adhesion; Cell adhesion molecules; chronic kidney disease; Chronic kidney failure; Creatinine; Diabetes; Dialysis; Echocardiography; endothelial activation; Endothelium; Glomerular filtration rate; Glomerular Filtration Rate - physiology; Growth factors; Heart failure; Hemodialysis; Humans; Hypertension; Intracellular; Kidney diseases; Kinases; Medical prognosis; Mortality; Natriuretic peptides; overhydration; Permeability; Plasma levels; Prospective Studies; Proteins; Renal Dialysis; Renal function; Renal Insufficiency, Chronic; Renal replacement therapy; Troponin I; Ultrasonic imaging; Vascular Cell Adhesion Molecule-1; Vascular endothelial growth factor; Vascular Endothelial Growth Factor C; Water content; angiopoietin-2; chronic kidney disease; overhydration; endothelial activation
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241210036

Volume status, congestion, endothelial activation, and injury all play roles in glomerular filtration rate (GFR) decline. In this study, we aimed to determine whether the plasma endothelial and overhydration markers could serve as independent predictors for dialysis initiation in patients with chronic kidney disease (CKD) 3b-5 (GFR < 45 mL/min/1.72 m ) and preserved ejection fraction. A prospective, observational study in a single academic center was conducted from March 2019 to March 2022. Plasma levels of angiopoietin (Ang)-2, Vascular Endothelial Growth Factor-C (VEGF-C), Vascular Cell Adhesion Molecule-1 (VCAM-1), Copeptin (CPP), beta-trace protein (BTP), brain natriuretic peptide (BNP), and cardiac troponin I (cTnI) were all measured. Lung ultrasound (US) B-lines, bioimpedance, and echocardiography with global longitudinal strain (GLS) were recorded. The study outcome was the initiation of chronic dialysis (renal replacement therapy) during 24 months of follow-up. A total of 105 consecutive patients with a mean eGFR of 21.3 mL/min/1.73 m were recruited and finally analyzed. A positive correlation between Ang-2 and VCAM-1 and BTP was observed. Ang-2 correlated positively with BNP, cTnI, sCr, E/e', and the extracellular water (ECW)/intracellular water (ICW) ratio (ECW/ICW). After 24 months, a deterioration in renal function was observed in 47 patients (58%). In multivariate regression analysis, both VCAM-1 and Ang-2 showed independent influences on risk of renal replacement therapy initiation. In a Kaplan-Meier analysis, 72% of patients with Ang-2 concentrations below the median (3.15 ng/mL) survived without dialysis for two years. Such an impact was not observed for GFR, VCAM, CCP, VEGF-C, or BTP. Endothelial activation, quantified by plasma levels of Ang-2, may play a key role in GFR decline and the need for dialysis initiation in patients with CKD 3b, 4, and 5.